US Patent Issued to Syngen Biotech on July 7 for "Use of Streptococcus Thermophilus ST7 for modulating immunity and against viruses" (Taiwanese Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,075, issued on July 7, was assigned to Syngen Biotech Co. Ltd. (Tainan City, Taiwan).

"Use of Streptococcus Thermophilus ST7 for modulating immunity and against viruses" was invented by Wei-Jen Chen (Tainan City, Taiwan), Yu-Lun Tsai (Tainan City, Taiwan) and Gilbert Aaron Lee (Taipei City, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention discloses use of Streptococcus thermophilus ST7 for modulating immunity, comprising using the Streptococcus thermophilus ST7 as an active ingredient for modulating immunity, wherein the Streptococcus thermophilus ST7 are deposited under the accession Nos. BCRC911126 and DSM34255. By admini...